Brittany D. Gomez

Brittany D. Gomez

Auto-generated profile, based on publicly available information

Brittany D. Gomez

Department of Immunology and Microbiology, University of Colorado Denver | Anschutz Medical Campus, School of Medicine, Aurora, CO, 80045, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZSZachary C. Stensland
Zachary C. Stensland
CMChristopher A. Magera
Christopher A. Magera
HBHali Broncucia
Hali Broncucia
BGBrittany D. Gomez
Brittany D. Gomez
NRNasha M. Rios-Guzman
Nasha M. Rios-Guzman
MSMia Smith
Mia Smith
Recent evidence suggests a role for B cells in the pathogenesis of young-onset type 1 diabetes (T1D), wherein rapid progression occurs. However, little is known regarding the specificity, phenotype, and function of B cells in young-onset T1D. We performed a cross-sectional analysis comparing insulin-reactive to tetanus-reactive B cells in the blood of T1D and controls using mass cytometry. Unsupervised clustering revealed the existence of a highly activated B cell subset we term BND2 that falls within the previously defined anergic BND subset. We found a specific increase in the frequency of insulin-reactive BND2 cells in the blood of young-onset T1D donors, which was further enriched in the pancreatic lymph nodes of T1D donors. The frequency of insulin-binding BND2 cells correlated with anti-insulin autoantibody levels. We demonstrate BND2 cells are pre-plasma cells and can likely act as APCs to T cells. These findings identify an antigen-specific B cell subset that may play a role in the rapid progression of young-onset T1D.

29 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
GVGabrielle Vragel
Gabrielle Vragel
KNKyra S. Noell
Kyra S. Noell
ATAshley Tseng
Ashley Tseng
RKRachael Kostelecky
Rachael Kostelecky
EAElizabeth A. Alexander
Elizabeth A. Alexander
LDLinda F van Dyk
Linda F van Dyk
The gammaherpesviruses (γHVs) establish a lifelong infection in their hosts, with the cellular outcome of infection intimately regulated by target cell type. Murine gammaherpesvirus 68 (MHV68), a small animal model of γHV infection, infects macrophages in vivo, resulting in a range of outcomes, from lytic replication to latent infection. Here, we have further investigated the nature of MHV68 macrophage infection using reductionist and primary in vivo infection studies. While MHV68 readily infected the J774 macrophage cell line, viral gene expression and replication were significantly impaired relative to a fully permissive fibroblast cell line. Lytic replication only occurred in a small subset of MHV68-infected J774 cells, despite the fact that these cells were fully competent to support lytic replication following pre-treatment with interleukin-4, a known potentiator of replication in macrophages. In parallel, we harvested virally-infected macrophages at 16 hours after MHV68 infection in vivo and analyzed gene expression by single cell RNA-sequencing. Among virally infected macrophages, only rare (0.25%) cells had lytic cycle gene expression, characterized by detection of multiple lytic cycle RNAs. In contrast, ∼50% of virally-infected macrophages were characterized by expression of ORF75A, ORF75B and/or ORF75C, in the absence of other detectable viral RNAs. Selective transcription of the ORF75 locus also occurred in MHV68-infected J774 cells. In total, these studies indicate that MHV68 efficiently infects macrophages, with the majority of cells characterized by an atypical state of restricted viral transcription, and only rare cells undergoing lytic replication. Importance The human gammaherpesviruses Epstein-Barr virus and Kaposi’s sarcoma associated herpesvirus are DNA viruses that cause lifelong infection and are associated with multiple diseases, especially in immunocompromised individuals. Murine gammaherpesvirus 68 (MHV68) is a powerful mouse model that permits close examination of these viruses. Previous studies of MHV68 identified that macrophages are an important in vivo target of infection; how infection within these cells is regulated remains incompletely understood. Here, we demonstrate that MHV68 infection of macrophages is characterized by two divergent outcomes across a population of infected cells: while a small subset of cells undergo lytic replication, to make new virus progeny, the majority of cells are characterized by an atypical, restricted form of infection characterized by a distinct viral gene transcription program not previously reported. These studies highlight important cell-type specific outcomes of gammaherpesvirus infection and identify a potential alternate program by which these viruses usurp macrophages.

13 October 2026 in iScience
Verified
Journal Article
Open access
GVGabrielle Vragel
Gabrielle Vragel
KNKyra S. Noell
Kyra S. Noell
ATAshley Tseng
Ashley Tseng
RKRachael Kostelecky
Rachael Kostelecky
EAElizabeth A. Alexander
Elizabeth A. Alexander
LDLinda F van Dyk
Linda F van Dyk